Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Personal protective equipment (PPE) needs in healthcare settings for the care of patients with suspected or confirmed novel coronavirus (2019-nCoV)

Flag for EU European Centre for Disease Prevention and Control on February 7th 2020
The aim of this document is to support public health preparedness planning with regard to personal protective equipment (PPE) needs in healthcare settings where patients suspected or confirmed to have been infected with the novel coronavirus 2019-nCoV are being treated.

Topics in this document

Related SDGs

Citations

Cited by 40 other policy documents (23 of them are from other policy sources)
 

Everything cited by this document (explore the cited scholarly articles) (explore the cited policy documents)

See details
Safe use of personal protective equipment in the treatment of infectious diseases of high consequence
European Centre for Disease Prevention and Control
Link in text to https://www.ecdc.europa.eu/en/publications-data/safe-use-personal-protective-equipment-treatment-infectious-diseases-high
On page 2
Link in text to https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/safe-use-of-ppe.pdf
On page 3
For more detailed information on the PPE for management of high consequence infectious diseases, please refer to the ECDC technical document Safe use of personal protective equipment in the treatment of infectious diseases of high consequence [5].
On page 2
5. European Centre for Disease Prevention and Control (ECDC). Safe use of personal protective equipment in the treatment of infectious diseases of high consequence Stockholm: ECDC; 2014. Available from: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/safe-use-of-ppe.pdf
On page 4
See details
Risk assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA − third update
European Centre for Disease Prevention and Control
It is expected that more cases will occur and countries have been asked to review their pandemic influenza preparedness planning [2].
On page 1
2. European Centre for Disease Prevention and Control (ECDC). Risk assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA − third update 2020 [02 February 2020]. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessmentoutbreak-acute-respiratory-syndrome-associated-novel-1
On page 4
Cited by others
Read article
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
New England Journal of Medicine (Massachusetts Medical Society)
Camilla Rothe et al. 2020
Other routes, such as contact with contaminated fomites and inhalation of aerosols produced during aerosol-generating procedures, seem to have been implicated [3].
On page 1
3. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine. 2020.
On page 4
See details
Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care
World Health Organization
Although airborne transmission is not considered the principal transmission route, we recommend a cautious approach due to possible transmission through aerosols [4].
On page 1
4. World Health Organization (WHO). Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care. WHO guidelines 2014 [17 January 2020]. Available from: https://www.who.int/csr/bioriskreduction/infection_control/publication/en/
On page 4